Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

270.12 USD -0.16 (-0.06%)
Official Closing Price Updated: 6:37 PM EST, Jan 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Rotating Into Health Care
There has been no more despised sector in the stock market for the past eight months than health care and biotech. However, a funny thing has happened over the last few weeks. Health care and biotech... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Best Stock Charts - April 13, 2016
We talk about the latest market overview by reviewing different charts. 
Tags Stocks / Equities Technology Services
From Blogs - TalkMarkets
These 12 U.S. companies have increased sales for at least 60 straight quarters
And their stock prices reflect that remarkable track record, writes Phil van Doorn. 
Tags Personal Finance BIIB Construction and Materials
From MarketWatch
Citi Surprised, Confused Amid Report Biogen May Divest Hemophilia Unit
Reuters reported on Friday that Biogen Inc (NASDAQ: BIIB) is exploring the sale of its hemophilia business. Citi’s Robyn ... 
Tags Long Ideas Benzinga Analyst Ratings
From Benzinga
Biotech Rally Fizzles: Needs Help from M&A
Biotech rally loses momentum but still is up for the week. 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Noteworthy Friday Option Activity: MKTO, ULTA, BIIB
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Marketo Inc (MKTO), where a total volume of 2,610 contracts has been traded thus... 
Tags Stocks
From Market News Video
Biogen explores sale of hemophilia assets -sources
April 8 (Reuters) - Biogen Inc, one of the world's largest biotechnology companies, is exploring a sale of its hemophilia treatments, as it increases its focus on core therapeutic areas, according to... 
Tags companyNews
From Reuters: Company News
Biotech, Markets, And Forcerank
Joe McCann of Slingshot Insights joins me to talk Biotech stocks, the market, and his latest creation ForceRank. (Audio Length: 00:37:53) 
Tags Pharma/Biotech Healthcare Stocks / Equities
From Blogs - TalkMarkets
Commit To Buy Biogen At $150, Earn 5.2% Using Options
Investors considering a purchase of Biogen Inc (BIIB) stock, but tentative about paying the going market price of $269.60/share, might benefit from considering selling puts among the alternative... 
Tags Stocks
From Market News Video
How One Analyst Is Playing The Biotech Rebound This Week
It's been a good week for biotech stocks, with the industry posting its biggest gains in seven years. Gilead Sciences, Inc. ... 
Tags Sean Udall Trading Ideas GILD
From Benzinga
Surprising Analyst 12-Month Target For SPXT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Morning Call For April 6, 2016
Jun E-mini S&Ps (ESM16 +0.18%) are up +0.18% and European stocks are up +0.10% as energy producing stocks are higher with a +2.90% rally in crude oil. 
Tags Commodities Energy Stocks / Equities
From Blogs - TalkMarkets
Cramer: Hope for biotech in the blast zone
Jim Cramer goes off the charts to determine if the biotech sector could come roaring back. 
Tags Mad Money Celgene Corp Biogen Inc
From CNBC.com News
The only three ETFs you need to own now
These funds pursue outperformance without taking on too much risk, writes Jeff Reeves. 
Tags Pharmaceuticals Food and Beverage MSFT
From MarketWatch
Trade of the Day: Nautilus, Inc. (NYSE:NLS)
 
Tags NYSE:MDT NASDAQ:BIIB NYSE:BMY
From InvestorPlace
Samsung brings in the lawyers for biosimilars push
SEOUL, April 4 (Reuters) - Samsung Bioepis Co Ltd, which aims to become a force in the fledgling biosimilar drugs industry, has filed a lawsuit against the originator of the world's best-selling drug,... 
Tags companyNews
From Reuters: Company News
Noteworthy Friday Option Activity: BIIB, CMCSA, MLM
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Biogen Inc (BIIB), where a total of 7,363 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Best Stock Charts - March 31, 2016
Latest market overview. (Video Length: 00:25:55) 
Tags Stocks / Equities ETF's
From Blogs - TalkMarkets
Blackrock Moves Up In Market Cap Rank, Passing Biogen
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Blackrock Incorporated (BLK) has taken over the #79 spot from Biogen Inc (BIIB), according to... 
Tags Stocks
From Market News Video
What's Going On With Kyle Bass And Biogen?
The Patent Trial and Appeal Board instituted an inter partes review (IPR) petition from Kyle Bass' Coalition for Affordable Drugs ... 
Tags Health Care BIIB Biotech
From Benzinga
Noteworthy Tuesday Option Activity: AMGN, BIIB, NAVI
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Amgen Inc (AMGN), where a total volume of 17,271 contracts has been traded thus far... 
Tags Stocks
From Market News Video
Eli Lilly and Co: Can LLY Stock Get Healthy Again?
 
Tags NYSE:BMY NYSE:NVS NYSE:MRK
From InvestorPlace
Busted Biotechs Week Ending 3/18/16: The Only Good News Could Be Holding The February Bottom
There is very little do with biotech stocks especially now that other sectors are outperforming. Here is the sector performance over the past month and since the February 11 bottom. 
Tags Stocks / Equities ETF's Healthcare
From Blogs - TalkMarkets
This Big Biotech ETF Faces a Key Technical Test
 
Tags ETF Investing NASDAQ:BIIB NASDAQ:AMGN
From InvestorPlace
Big Biotech ETF Faces Key Technical Test
This year, the weakest sector has been health care stocks. The Health Care Select Sector SPDR is still down over 8% as SPY begins to peak its head above the flat line. 
Tags Pharma/Biotech Stocks / Equities ETF's
From Blogs - TalkMarkets
10 Shaky Stocks That Could Fall 10% or More
 
Tags NASDAQ:BIIB NYSE:VRX NYSE:KEY
From InvestorPlace
These companies get the most bang for the buck with their buybacks
Even as company earnings decline, more activist investors are demanding, and succeeding, in getting bosses to spend money on stock buybacks and dividends. But that isn’t always a smart move. 
Tags MU M&A Market News
From MarketWatch
A Rare Opportunity With A Biotechnology ETF
A frequent criticism of biotechnology stocks is that they usually trade at rich multiples, making the industry appear expensive not ... 
Tags Trading Ideas ETFs GILD
From Benzinga
7 Big Pharma & Biotech Stocks to Sell or Short
 
Tags NYSE:PFE NASDAQ:SHPG NASDAQ:CELG
From InvestorPlace
Biogen Inc: Regenerate Profits in a Bear-Trapped BIIB
 
Tags NASDAQ:BIIB Trading Advice
From InvestorPlace
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.